544 related articles for article (PubMed ID: 30281030)
1. Myelin oligodendrocyte glycoprotein-IgG-associated optic neuritis.
Chun BY; Cestari DM
Curr Opin Ophthalmol; 2018 Nov; 29(6):508-513. PubMed ID: 30281030
[TBL] [Abstract][Full Text] [Related]
2. Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis.
Jitprapaikulsan J; Chen JJ; Flanagan EP; Tobin WO; Fryer JP; Weinshenker BG; McKeon A; Lennon VA; Leavitt JA; Tillema JM; Lucchinetti C; Keegan BM; Kantarci O; Khanna C; Jenkins SM; Spears GM; Sagan J; Pittock SJ
Ophthalmology; 2018 Oct; 125(10):1628-1637. PubMed ID: 29716788
[TBL] [Abstract][Full Text] [Related]
3. Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis.
Chen JJ; Bhatti MT
Curr Opin Neurol; 2020 Feb; 33(1):47-54. PubMed ID: 31743235
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial.
Chen JJ; Tobin WO; Majed M; Jitprapaikulsan J; Fryer JP; Leavitt JA; Flanagan EP; McKeon A; Pittock SJ
JAMA Ophthalmol; 2018 Apr; 136(4):419-422. PubMed ID: 29470571
[TBL] [Abstract][Full Text] [Related]
5. Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.
Chen JJ; Flanagan EP; Jitprapaikulsan J; López-Chiriboga ASS; Fryer JP; Leavitt JA; Weinshenker BG; McKeon A; Tillema JM; Lennon VA; Tobin WO; Keegan BM; Lucchinetti CF; Kantarci OH; McClelland CM; Lee MS; Bennett JL; Pelak VS; Chen Y; VanStavern G; Adesina OO; Eggenberger ER; Acierno MD; Wingerchuk DM; Brazis PW; Sagen J; Pittock SJ
Am J Ophthalmol; 2018 Nov; 195():8-15. PubMed ID: 30055153
[TBL] [Abstract][Full Text] [Related]
6. Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies.
Lee HJ; Kim B; Waters P; Woodhall M; Irani S; Ahn S; Kim SJ; Kim SM
J Neuroinflammation; 2018 Oct; 15(1):302. PubMed ID: 30382857
[TBL] [Abstract][Full Text] [Related]
7. Optic neuritis of MOG-IgG-associated autoimmune disorders: a case report.
Li T; Zhou J; Yan X; Duan R; Zhu X
BMC Ophthalmol; 2021 Jan; 21(1):24. PubMed ID: 33422038
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis.
Kezuka T; Ishikawa H
Jpn J Ophthalmol; 2018 Mar; 62(2):101-108. PubMed ID: 29445944
[TBL] [Abstract][Full Text] [Related]
9. Population-Based Incidence of Optic Neuritis in the Era of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies.
Hassan MB; Stern C; Flanagan EP; Pittock SJ; Kunchok A; Foster RC; Jitprapaikulsan J; Hodge DO; Bhatti MT; Chen JJ
Am J Ophthalmol; 2020 Dec; 220():110-114. PubMed ID: 32707199
[TBL] [Abstract][Full Text] [Related]
10. Myelin oligodendrocyte glycoprotein-positive optic neuritis masquerading as pseudotumor cerebri at presentation.
Lotan I; Brody J; Hellmann MA; Bialer O; Ganelin-Cohen E; Michaeli N; Marignier R; Stiebel-Kalish H
J Neurol; 2018 Sep; 265(9):1985-1988. PubMed ID: 29938337
[TBL] [Abstract][Full Text] [Related]
11. Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis: an update.
Messias K; Marques VD; Messias A
Arq Bras Oftalmol; 2023; 86(1):83-92. PubMed ID: 35170658
[TBL] [Abstract][Full Text] [Related]
12. Myelin Oligodendrocyte Glycoprotein-IgG-positive Recurrent Bilateral Optic Papillitis with Serous Retinal Detachment.
Kon T; Hikichi H; Ueno T; Suzuki C; Nunomura J; Kaneko K; Takahashi T; Nakashima I; Tomiyama M
Intern Med; 2018 Nov; 57(22):3307-3312. PubMed ID: 29780155
[TBL] [Abstract][Full Text] [Related]
13. Relapsing optic neuritis and meningoencephalitis in a child: case report of delayed diagnosis of MOG-IgG syndrome.
Zhong X; Chang Y; Tan S; Wang J; Sun X; Wu A; Peng L; Lau AY; Kermode AG; Qiu W
BMC Neurol; 2019 May; 19(1):94. PubMed ID: 31072329
[TBL] [Abstract][Full Text] [Related]
14. Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands.
van Pelt ED; Wong YY; Ketelslegers IA; Hamann D; Hintzen RQ
Eur J Neurol; 2016 Mar; 23(3):580-7. PubMed ID: 26593750
[TBL] [Abstract][Full Text] [Related]
15. Clinical Characteristics of Pediatric Optic Neuritis With Myelin Oligodendrocyte Glycoprotein Seropositive: A Cohort Study.
Chen Q; Zhao G; Huang Y; Li Z; Sun X; Lu P; San Y; Wang M; Tian G
Pediatr Neurol; 2018 Jun; 83():42-49. PubMed ID: 29778487
[TBL] [Abstract][Full Text] [Related]
16. Persistent MOG-IgG positivity is a predictor of recurrence in MOG-IgG-associated optic neuritis, encephalitis and myelitis.
Oliveira LM; Apóstolos-Pereira SL; Pitombeira MS; Bruel Torretta PH; Callegaro D; Sato DK
Mult Scler; 2019 Dec; 25(14):1907-1914. PubMed ID: 30417715
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics and Treatment of MOG-IgG-Associated Optic Neuritis.
Tajfirouz DA; Bhatti MT; Chen JJ
Curr Neurol Neurosci Rep; 2019 Nov; 19(12):100. PubMed ID: 31773369
[TBL] [Abstract][Full Text] [Related]
18. Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a Japanese boy with recurrent optic neuritis.
Tsuburaya RS; Miki N; Tanaka K; Kageyama T; Irahara K; Mukaida S; Shiraishi K; Tanaka M
Brain Dev; 2015 Jan; 37(1):145-8. PubMed ID: 24582475
[TBL] [Abstract][Full Text] [Related]
19. MOG-IgG associated optic neuritis is not multiple sclerosis.
Costa BKD; Passos GRD; Becker J; Sato DK
Arq Neuropsiquiatr; 2017 Oct; 75(10):687-691. PubMed ID: 29166458
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of myelin oligodendrocyte glycoprotein seropositive optic neuritis: a cohort study in Shanghai, China.
Zhao G; Chen Q; Huang Y; Li Z; Sun X; Lu P; Yan S; Wang M; Tian G
J Neurol; 2018 Jan; 265(1):33-40. PubMed ID: 29101456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]